Vitamin D Analogs for the Treatment of Secondary Hyperparathyroidism

Publisher： Karger

E-ISSN： 1421-9735|20|1|109-112

ISSN： 0253-5068

Source： Blood Purification, Vol.20, Iss.1, 2002-01, pp. : 109-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Secondary Hyperparathyroidism in Hemodialyzed Patients with High-Dose Calcium Carbonate without Vitamin D3 Supplements

By  

American Journal of Nephrology, Vol. 19, Iss. 3, 1999-06 ,pp. : 428-432

Karger

Access to resources Recommend Favorite

Analysis of α-Klotho, Fibroblast Growth Factor-, Vitamin-D and Calcium-Sensing Receptor in 70 Patients with Secondary Hyperparathyroidism

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 1, 2013-03 ,pp. : 84-94

Karger

Access to resources Recommend Favorite

Yet Another Vitamin D Analogue for the Management of Secondary Hyperparathyroidism: A Triton among the Minnows?

By  

American Journal of Nephrology, Vol. 43, Iss. 3, 2016-04 ,pp. : 221-224

Karger

Access to resources Recommend Favorite

Impact of Phosphorus Restriction and Vitamin D-Substitution on Secondary Hyperparathyroidism in a Proteinuric Mouse Model

By  

Kidney and Blood Pressure Research, Vol. 40, Iss. 2, 2015-03 ,pp. : 153-165

Karger

Access to resources Recommend Favorite

Effects of Treatment of Secondary Hyperparathyroidism on the Lipid Profile in Patients on Hemodialysis

By  

Blood Purification, Vol. 16, Iss. 1, 1998-02 ,pp. : 22-29

Karger

Access to resources Recommend Favorite